54 related articles for article (PubMed ID: 37589934)
1. A bromodomain-independent mechanism of gene regulation by the BET inhibitor JQ1: direct activation of nuclear receptor PXR.
Huber AD; Poudel S; Wu J; Miller DJ; Lin W; Yang L; Bwayi MN; Rimmer MA; Gee RRF; Seetharaman J; Chai SC; Chen T
Nucleic Acids Res; 2024 Feb; 52(4):1661-1676. PubMed ID: 38084912
[TBL] [Abstract][Full Text] [Related]
2. BET Protein Inhibitor JQ1 Ameliorates Experimental Peritoneal Damage by Inhibition of Inflammation and Oxidative Stress.
Marchant V; Trionfetti F; Tejedor-Santamaria L; Rayego-Mateos S; Rotili D; Bontempi G; Domenici A; Menè P; Mai A; Martín-Cleary C; Ortiz A; Ramos AM; Strippoli R; Ruiz-Ortega M
Antioxidants (Basel); 2023 Nov; 12(12):. PubMed ID: 38136175
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated exportin-6 upregulation inhibits the transcriptionally repressive and anticancer effects of nuclear profilin-1.
Zhu C; Kim SJ; Mooradian A; Wang F; Li Z; Holohan S; Collins PL; Wang K; Guo Z; Hoog J; Ma CX; Oltz EM; Held JM; Shao J
Cell Rep; 2021 Feb; 34(7):108749. PubMed ID: 33596420
[TBL] [Abstract][Full Text] [Related]
4. Zinc-chelating BET bromodomain inhibitors equally target islet endocrine cell types.
Jones Lipinski RA; Stancill JS; Nuñez R; Wynia-Smith SL; Sprague DJ; Nord JA; Bird A; Corbett JA; Smith BC
Am J Physiol Regul Integr Comp Physiol; 2024 Apr; ():. PubMed ID: 38618911
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 Induces Stem Cell Propagation through Liaison with the Sortilin-Progranulin Axis in Breast Cancer.
Berger K; Persson E; Gregersson P; Ruiz-Martínez S; Jonasson E; Ståhlberg A; Rhost S; Landberg G
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136303
[TBL] [Abstract][Full Text] [Related]
6. Chemical Catalysis Guides Structural Identification for the Major
Holmes S; Jain P; Rodriguez KG; Williams J; Yu Z; Cerda-Smith C; Samuel ELG; Campbell J; Hakenjos JM; Monsivais D; Li F; Chamakuri S; Matzuk MM; Santini C; MacKenzie KR; Young DW
ACS Med Chem Lett; 2024 Jan; 15(1):107-115. PubMed ID: 38229743
[TBL] [Abstract][Full Text] [Related]
7. Single-cell trajectory analysis reveals a CD9 positive state to contribute to exit from stem cell-like and embryonic diapause states and transit to drug-resistant states.
Li X; Poire A; Jeong KJ; Zhang D; Chen G; Sun C; Mills GB
Cell Death Discov; 2023 Aug; 9(1):285. PubMed ID: 37542044
[TBL] [Abstract][Full Text] [Related]
8. Effects of bromodomain and extra-terminal inhibitor JQ1 and interleukin-6 on breast cancer cells.
Sharifhoseini A; Heshmati M; Soltani A; Entezam M; Shirzad H; Sedehi M; Judd BA; Jami MS; Ghatrehsamani M
Mol Biol Rep; 2023 Oct; 50(10):8319-8328. PubMed ID: 37589934
[TBL] [Abstract][Full Text] [Related]
9. A novel dual epigenetic approach targeting BET proteins and HDACs in Group 3 (MYC-driven) Medulloblastoma.
Kling MJ; Kesherwani V; Mishra NK; Alexander G; McIntyre EM; Ray S; Challagundla KB; Joshi SS; Coulter DW; Chaturvedi NK
J Exp Clin Cancer Res; 2022 Nov; 41(1):321. PubMed ID: 36357906
[TBL] [Abstract][Full Text] [Related]
10. The Bromodomain Inhibitor JQ1 and the Histone Deacetylase Inhibitor Panobinostat Synergistically Reduce N-Myc Expression and Induce Anticancer Effects.
Shahbazi J; Liu PY; Atmadibrata B; Bradner JE; Marshall GM; Lock RB; Liu T
Clin Cancer Res; 2016 May; 22(10):2534-44. PubMed ID: 26733615
[TBL] [Abstract][Full Text] [Related]
11. Co-targeting BET bromodomain BRD4 and RAC1 suppresses growth, stemness and tumorigenesis by disrupting the c-MYC-G9a-FTH1axis and downregulating HDAC1 in molecular subtypes of breast cancer.
Ali A; Shafarin J; Unnikannan H; Al-Jabi N; Jabal RA; Bajbouj K; Muhammad JS; Hamad M
Int J Biol Sci; 2021; 17(15):4474-4492. PubMed ID: 34803511
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of BET bromodomain targets genetically diverse glioblastoma.
Cheng Z; Gong Y; Ma Y; Lu K; Lu X; Pierce LA; Thompson RC; Muller S; Knapp S; Wang J
Clin Cancer Res; 2013 Apr; 19(7):1748-59. PubMed ID: 23403638
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancer.
Shimamura T; Chen Z; Soucheray M; Carretero J; Kikuchi E; Tchaicha JH; Gao Y; Cheng KA; Cohoon TJ; Qi J; Akbay E; Kimmelman AC; Kung AL; Bradner JE; Wong KK
Clin Cancer Res; 2013 Nov; 19(22):6183-92. PubMed ID: 24045185
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
